Public Market Listing
SUNPHARMANSE
Live quotes, historical charts, and market capitalization for Sun Pharmaceutical Industries are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(5 total)
5Total Assets
4Approved
0Phase 3 / Filed
1Phase 1–2 / Early
6Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Approved | Glucocorticoid receptor | Inflammatory Bowel Disease Crohn's Disease | |
Duloxetine(Cymbalta) | Approved | Serotonin/norepinephrine transporter · Serotonin and norepinephrine transporters (SERT/NET)Small molecule | Diabetic Peripheral Neuropathic Pain |
| Approved | GABA-A receptorSmall molecule | Epilepsy | |
tildrakizumab(Ilumya) | Approved | IL-23 p19Monoclonal antibody | Psoriatic ArthritisPsoriasis |
| Phase 2 | GLP-1 receptorPeptide | Obesity |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.